Skip to main
ABSI

Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp (ABSI) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Absci is primed to disrupt the hair loss treatment market with its novel biologic, ABS-201, which utilizes advanced AI and synthetic biology to target the PRLR pathway with an extended half-life. The company has a comprehensive understanding of the mechanisms involved in hair growth and have shown promising preclinical and clinical results, with a potentially superior product profile compared to existing hair loss treatments. This, combined with a large and growing market, suggests strong potential for Absci's success and future growth.

Bears say

Absci is heavily reliant on external funding as it expands its discovery platform and takes its candidates through clinical trials, which may be difficult to obtain on favorable terms. Its existing partnerships may not reach fruition or continue to contribute significant revenues, and there are potential safety and competition risks surrounding ABS-201's effectiveness in promoting hair growth.

Absci Corp (ABSI) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Absci Corp (ABSI) Forecast

Analysts have given Absci Corp (ABSI) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Absci Corp (ABSI) has a Strong Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.97, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.97, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Absci Corp (ABSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.